Page last updated: 2024-09-03

tazobactam and Burkholderia pseudomallei Infection

tazobactam has been researched along with Burkholderia pseudomallei Infection in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Meesing, A; Sribenjalux, W; Wonglakorn, L1
Cronin, K; Engler, C; Norton, R; Parsonson, F; Slack, A1
Subaalaxmi, MV1

Other Studies

3 other study(ies) available for tazobactam and Burkholderia pseudomallei Infection

ArticleYear
In vitro susceptibility of Burkholderia pseudomallei isolates from Thai patients to ceftolozane/tazobactam and ceftazidime/avibactam.
    Journal of global antimicrobial resistance, 2022, Volume: 28

    Topics: Azabicyclo Compounds; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Humans; Melioidosis; Pseudomonas aeruginosa; Tazobactam; Thailand

2022
Activity of Ceftolozane-Tazobactam against
    The American journal of tropical medicine and hygiene, 2018, Volume: 99, Issue:2

    Topics: Anti-Bacterial Agents; Burkholderia pseudomallei; Cephalosporins; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Humans; Melioidosis; Microbial Sensitivity Tests; Tazobactam

2018
Septicemic melioidosis.
    The Journal of the Association of Physicians of India, 2010, Volume: 58

    Topics: Humans; Male; Melioidosis; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Time Factors; Treatment Outcome

2010